ITCI
Intra-Cellular Therapies, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website intracellulartherapies.com
- Employees(FY) 561
- ISIN US46116X1019
Performance
1W
1M
3M
6M
YTD
1Y
Profile
Investment Analysis Report: ITCI
Overview
In this investment analysis report, we will delve into a comprehensive evaluation of ITCI, a company operating in the Health Technology sector within the Pharmaceuticals: Major industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operatin...
Technical Analysis of ITCI 2024-07-18
Based on the provided technical analysis data for ITCI over the last five trading days, we can derive insights into potential price movements in the coming days. The analysis will focus on trend indicators, momentum indicators, volatility indicators, and volume indicators to form a comprehensive view of the stock's behavior.
Overview
The recent ...
Recent News & Updates
- 2024-07-24 08:00
- 2024-07-23 20:00
- 2024-07-22 10:39
- 2024-07-21 10:16
- 2024-07-09 09:55
- 2024-07-09 07:39
- 2024-07-08 21:55
- 2024-06-24 09:52
- 2024-06-23 21:52
- 2024-06-20 14:37
Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87(Investor's Business Daily)
- 2024-06-20 12:47
- 2024-06-20 12:45
- 2024-06-20 12:42
- 2024-06-20 12:41
- 2024-06-20 12:37
- 2024-06-20 11:39
- 2024-06-19 10:27
- 2024-06-19 06:27
- 2024-06-18 22:27
- 2024-06-18 18:27
- 2024-06-18 13:34
Intra-Cellular Therapies edges closer to FDA win for Caplyta in depression(Clinical Trials Arena)
- 2024-06-18 09:33
Intra-Cellular Therapies Eyes $1.7 Billion Opportunity After Phase 3 Win(Investor's Business Daily)
- 2024-06-18 08:53
- 2024-06-18 07:30
- 2024-06-18 07:30
- 2024-06-17 19:30
- 2024-06-10 08:00
- 2024-06-09 20:00
- 2024-06-06 11:31
- 2024-06-05 23:31